HSA · registration DE0503793Fresenius Medical Care Sodium Citrate 4% w/v Safe Lock
- Registration number
- DE0503793
- Model name
- Sodium Citrate 4% w/v
- Model identifier
- F00008105
- Registration date
- November 05, 2019
- Source update date
- May 02, 2024
- Risk class
- Class C
- Product owner
- Fresenius Medical Care AG
- Registrant / registration holder
- FRESENIUS MEDICAL CARE SINGAPORE PTE. LTD.
Sodium citrate 4% solution is intended for regional anticoagulation in continuous renal replacement therapies (CRRT) in adults: - Continuous veno-venous haemodialysis (Ci-Ca® CVVHD) - Post-dilution continuous veno-venous haemodiafiltration (Ci-Ca® post CVVHDF) Sodium citrate 4% solution must only be used with Fresenius Medical Care CRRT devices multiFiltrate and multiFiltratePRO for the mentioned blood processing therapies, and having integrated pumps to administer citrate and calcium.
- Product owner address
- Else-Kroner-Str. 1, 61352 Bad Homburg, Germany
- Registrant address
- 250 NORTH BRIDGE ROAD, #05-01, RAFFLES CITY TOWER, Singapore 179101
This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.